Evidence map›Paper›PMID 42734806›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2027

Nanopore Sequencing for Chikungunya Virus: Principles and Application.

Talita Émile Ribeiro Adelino, Joilson Xavier, Vagner Fonseca, Marta Giovanetti

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Talita Émile Ribeiro AdelinoCentral Public Health Laboratory of Minas Gerais (Lacen-MG), Ezequiel Dias Foundation - Funed, Belo Horizonte, Minas Gerais, Brazil.
Joilson XavierInstitut für Virologie, Freie Universität Berlin, Robert von Ostertag-Straße 8, Berlin, 14163, Germany.
Vagner FonsecaInstituto René Rachou - Fiocruz Minas, Belo, Horizonte, Minas Gerais, Brazil.
Marta GiovanettiDepartment of Science and Bio-Technology, Universita Campus Bio-Medico di, Roma, Italy. giovanetti.marta@gmail.com.ORCID http://orcid.org/0000-0002-5849-7326

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanopore sequencing is transforming viral genomics through real-time, portable, long-read analysis of RNA and DNA. Unlike traditional short-read platforms, it detects nucleotide sequences by measuring ionic current changes as nucleic acids pass through nanoscale pores, enabling direct single-molecule sequencing and base modification detection. Its simplicity, flexibility, and capacity for ultra-long reads make it ideal for resolving complex genomic regions, structural variants, and full viral genomes. These advantages have accelerated its use in pathogen surveillance and outbreak response, especially in resource-limited settings. For chikungunya virus (CHIKV), nanopore sequencing allows rapid, culture-independent recovery of complete genomes from clinical and vector samples, enabling real-time tracking of viral diversity, evolution, and spread. Experiences from Ebola, Zika, and COVID-19 have demonstrated the power of portable sequencing, now applied to CHIKV monitoring. Advances in tools such as Guppy, Dorado, Minimap2, and Medaka enhance read quality, consensus accuracy, and downstream analyses. Despite challenges in basecalling and error correction, robust quality control pipelines ensure reliable results. Ongoing improvements in chemistry, flow cell design, and machine learning will further enhance fidelity and throughput, establishing nanopore sequencing as a cornerstone of CHIKV genomic surveillance and epidemic preparedness.

Indexed as

Chikungunya FeverChikungunya virusNanopore SequencingAnimalsGenome, ViralGenomicsHigh-Throughput Nucleotide SequencingHumansRNA, ViralRNA, ViralArbovirus monitoringChikungunya virusGenomic surveillanceNanopore sequencingViral evolution

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.